Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population

Annals of the Rheumatic Diseases

Volumn 72, Issue 9, 2013, Pages 1517-1523

  Verstappen, Suzanne M M ^a   Lunt, Mark ^a   Luben, Robert N ^b   Chipping, Jackie ^c   Marshall, Tarnya ^c   Khaw, Kay Tee ^b   Wareham, Nick ^b   Dixon, William G ^a   Bruce, Ian N ^a   Symmons, Deborah P M ^a,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^d Manchester NIHR Biomedical Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL DISABILITY; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NORFOLK ARTHRITIS REGISTER; POLYARTHRITIS; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RESTRICTIVE LUNG DISEASE; SMOKING; SPIROMETRY; UNITED KINGDOM;

ARTHRITIS; EPIDEMIOLOGY; OUTCOMES RESEARCH;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; COMORBIDITY; DEMOGRAPHY; FEMALE; GREAT BRITAIN; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; REGISTRIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SMOKING;

EID: 84881481577     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201698     Document Type: Article

References (33)

1. Nannini C, Ryu JH, Matteson EL. Lung disease in rheumatoid arthritis. Curr Opin Rheumatol 2008;20:340-6. (Pubitemid 351483326)
2. Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7. (Pubitemid 36886405)
3. Bartels CM, Bell CL, Shinki K, et al. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford) 2010;49:1670-5.
4. Metafratzi ZM, Georgiadis AN, Ioannidou CV, et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007;36:338-44. (Pubitemid 350034803)
5. Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 2010;49:1483-9.
6. Naz SM, Symmons DP. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871-83. (Pubitemid 47377805)
7. Amital A, Shitrit D, Adir Y. The lung in rheumatoid arthritis. Presse Med 2011;40:e31-48.
8. Fuld JP, Johnson MK, Cotton MM, et al. A longitudinal study of lung function in nonsmoking patients with rheumatoid arthritis. Chest 2003;124:1224-31. (Pubitemid 37290030)
9. Geddes DM, Webley M, Emerson PA. Airways obstruction in rheumatoid arthritis. Ann Rheum Dis 1979;38:222-5. (Pubitemid 9236368)
10. Pappas DA, Giles JT, Connors G, et al. Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study. Arthritis Res Ther 2010;12:R104.
11. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528-35. (Pubitemid 27351990)
12. Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996;39:1711-19. (Pubitemid 26331025)
13. Charles PJ, Sweatman MC, Markwick JR, et al. HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis. Dis Markers 1991;9:97-101.
14. Symmons DP, Barrett EM, Bankhead CR, et al. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994;33:735-9. (Pubitemid 24249180)
15. Thomson W, Harrison B, Ollier B, et al. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999;42:757-62. (Pubitemid 29171997)
16. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
17. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986;25:206-9. (Pubitemid 16033804)
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
19. National Clinical Guideline Centre. Management of adults with chronic obstructive pulmonary disease in primary and secondary care: update guideline (draft). NICE, 2009. http://www.nice.org.uk/nicemedia/pdf/ COPDDraftConsultationGuideline.pdf
20. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6. (Pubitemid 29296676)
21. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965;1:775-9.
22. Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999;80 (Suppl 1):95-103. (Pubitemid 29389613)
23. McFadden E, Luben R, Wareham N, et al. How far can we explain the social class differential in respiratory function? A cross-sectional population study of 21,991 men and women from EPIC-Norfolk. Eur J Epidemiol 2009;24:193-201.
24. Falaschetti E, Laiho J, Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J 2004;23:456-63. (Pubitemid 38344386)
25. Purdy S, Griffin T, Salisbury C, et al. Emergency respiratory admissions: influence of practice, population and hospital factors. J Health Serv Res Policy 2011;16:133-40.
26. Shavit O, Swern A, Dong Q, et al. Impact of smoking on asthma symptoms, healthcare resource use, and quality of life outcomes in adults with persistent asthma. Qual Life Res 2007;16:1555-65. (Pubitemid 350059906)
27. Kremer JM, Alarcon GS, Weinblatt ME, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997;40:1829-37. (Pubitemid 27452534)
28. Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009;68:1100-4.
29. Verstappen SM, Bakker MF, Heurkens AH, et al. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Ann Rheum Dis 2010;69:1044-8.
30. Dawson JK, Graham DR, Desmond J, et al. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Rheumatology (Oxford) 2002;41:262-7. (Pubitemid 34537861)
31. Youssef AA, Machaly SA, El-Dosoky ME, et al. Respiratory symptoms in rheumatoid arthritis: relation to pulmonary abnormalities detected by high-resolution CT and pulmonary functional testing. Rheumatol Int 2012;32:1985-95.
32. Biederer J, Schnabel A, Muhle C, et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004;14:272-80. (Pubitemid 38181084)
33. Nacul L, Soljak M, Samarasundera E, et al. COPD in England: a comparison of expected, model-based prevalence and observed prevalence from general practice data. J Public Health (Oxf ) 2011;33:108-16.